The construction of optimal designs for dose-escalation studies
نویسندگان
چکیده
Methods for the construction of A-,MV -,Dand E-optimal designs for dose-escalation studies are presented. Algebraic results proved elusive and explicit expressions for the requisite optimal designs are only given for a restricted class of traditional designs. Recourse to numerical procedures and heuristics is therefore made. Complete enumeration of all possible designs is discussed but is, as expected, highly computer intensive. Two exchange algorithms, one based on block exchanges and termed the Block Exchange Algorithm and the other a candidate-set-free algorithm based on individual exchanges and termed the Best Move Algorithm, are therefore introduced. Of these the latter is the most computationally effective. The methodology is illustrated by means of a range of carefully selected examples.
منابع مشابه
Adaptive Designs for Dose Escalation Studies
In Phase I dose escalation studies the 3+3 design is a commonly used method. We suggest a modification of this method to include a parametric model and the concepts of optimal design theory, with the aim of improving this method. The performance of the original and the new approach are investigated by simulations.
متن کاملEscalation with Overdose Control is More Efficient and Safer than Accelerated Titration for Dose Finding
The standard 3 + 3 or "modified Fibonacci" up-and-down (MF-UD) method of dose escalation is by far the most used design in dose-finding cancer trials. However, MF-UD has always shown inferior performance when compared with its competitors regarding number of patients treated at optimal doses. A consequence of using less effective designs is that more patients are treated with doses outside the ...
متن کاملHow first-time-in-human studies are being performed: a survey of phase I dose-escalation trials in healthy volunteers published between 1995 and 2004.
First-time-in-human studies are small, time-lagged dose-escalation studies including volunteer subjects evaluating safety and tolerability. There is little consensus in the design of a first-time-in-human study, and it is difficult to get an overview of studies performed. One hundred five studies comprising 3323 healthy volunteers published in the 5 major clinical pharmacology journals since 19...
متن کاملDose Escalation Methods in Phase I Cancer Clinical Trials
Phase I clinical trials are an essential step in the development of anticancer drugs. The main goal of these studies is to establish the recommended dose and/or schedule of new drugs or drug combinations for phase II trials. The guiding principle for dose escalation in phase I trials is to avoid exposing too many patients to subtherapeutic doses while preserving safety and maintaining rapid acc...
متن کاملEfficiency of New Dose Escalation Designs in Dose-Finding Phase I Trials of Molecularly Targeted Agents
BACKGROUND Statistical simulations have consistently demonstrated that new dose-escalation designs such as accelerated titration design (ATD) and continual reassessment method (CRM)-type designs outperform the standard "3+3" design in phase I cancer clinical trials. METHODS We evaluated the actual efficiency of different dose escalation methods employed in first-in-human phase I clinical tria...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Statistics and Computing
دوره 24 شماره
صفحات -
تاریخ انتشار 2014